መነሻ › አቶፒክ ደርማቲቲስ (ኤክዜማ) › ኢሊኖይ
በኢሊኖይ ለአቶፒክ ደርማቲቲስ (ኤክዜማ) የሚደረጉ ክሊኒካዊ ጥናቶች
ለአቶፒክ ደርማቲቲስ (ኤክዜማ) የሚደረጉ 10 ጥናቶች በኢሊኖይ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በኢሊኖይ ውስጥ ያሉ ከተሞች
Official study text (English)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Sneeze, Wheeze, & Itch Associates, LLC- Site Number : 8400029, Normal
- Rosalind Franklin University of Medicine and Science- Site Number: 8400056, North Chicago
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07290803Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07298395A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Skokie
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07003425A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Endeavor Health, Skokie
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 2, Rolling Meadows
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Northwestern University Feinberg School of Medicine /ID# 265117, Chicago
- Sneeze Wheeze & Itch Associates /ID# 267238, Normal
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 11 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT06461897A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- DeNova Research /ID# 264513, Chicago
- Northwestern University Feinberg School of Medicine /ID# 264983, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 63 · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT06389136Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Northwestern University Feinberg School of Medicine: Department of Dermatology, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 6 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁላይ 2026 · NCT06504160Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
- Lurie Children's Hospital/Northwestern University, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ6 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ27 ኤፕሪ 2026 · NCT05042258Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7058, Chicago
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ማርች 2026 · NCT06988605ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።